CRRVF - CVR Medical Corp.

Other OTC - Other OTC Delayed Price. Currency in USD
0.3646
+0.0005 (+0.1373%)
At close: 3:52PM EST
Stock chart is not supported by your current browser
Previous Close0.3641
Open0.3567
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.3502 - 0.3646
52 Week Range0.2210 - 0.5677
Volume24,047
Avg. Volume104,545
Market Cap23.312M
BetaN/A
PE Ratio (TTM)N/A
EPS (TTM)-0.1310
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Newsfile4 days ago

    Critical Milestone: CVR Medical to Launch Pivotal Trials

    Vancouver, British Columbia--(Newsfile Corp. - February 20, 2018) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") announces the launch of pivotal clinical trials beginning Monday March 5, 2018 for the Carotid Stenotic Scan (CSS) device. This anticipated milestone represents the final phase of clinical substantiation which CVR will use to support the upcoming FDA submission. Initially, Thomas Jefferson University Hospital (Philadelphia, PA) and Henry Ford Hospital (Detroit, MI) ...

  • Newsfile11 days ago

    CVR Medical Adds Two Wireless CSS Devices to Methodist Hospital Expanding Clinical Substantiation Data for FDA Submission

    Vancouver, British Columbia--(Newsfile Corp. - February 13, 2018) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") announces placement of two additional wireless Carotid Stenotic Scan (CSS) devices into clinical trials at historic Methodist Hospital, part of the Thomas Jefferson University Hospital System. This deployment will be combined with the three wireless CSS devices already in use across the Thomas Jefferson University Hospital footprint. This critical milestone will assist ...

  • CVR Medical, Canon Showcasing Carotid Stenotic Scan (CSS) at PLASTEC West 2018
    Newsfile16 days ago

    CVR Medical, Canon Showcasing Carotid Stenotic Scan (CSS) at PLASTEC West 2018

    Vancouver, British Columbia--(Newsfile Corp. - February 8, 2018) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical" or "CVR") has joined Canon Virginia, Inc. (CVI) at PLASTEC West (February 6 - 8, 2018), the largest domestic conference and expo for advanced design and manufacturing of plastics technologies. CVI, subsidiary of Canon U.S.A., Inc, is the sole manufacturer of the cart for CVR Medical's "Carotid Stenotic Scan (CSS)" device.CVI is sharing a ...

  • Newsfile18 days ago

    CVR Medical Moving Forward With Touch Panels From Hitachi High Technologies America

    Vancouver, British Columbia--(Newsfile Corp. - February 6, 2018) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical" or "CVR") announces the placement of an initial order of touch panel PC's for its "Carotid Stenotic Scan (CSS)" device. This order represents the preliminary inventory build necessary for an FDA submission and subsequent market launch. Hitachi High Technologies America, Inc. ("HTA") designed the unique core processor for the CSS, which CVR believes ...

  • Newsfile23 days ago

    CVR Medical Entering Into Pre-Pivotal Trial Phase A Step Closer To FDA Clearance

    Vancouver, British Columbia--(Newsfile Corp. - February 1, 2018) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") announces the launch of their Pre-Pivotal Trial clinical substantiation phase for the "Carotid Stenotic Scan (CSS)" device. This critical stage, prior to launch of final phase Pivotal Trials, will be conducted at Thomas Jefferson University Hospital (Philadelphia, PA), Henry Ford Hospital (Detroit, MI), and several other top-tier clinical research institutions within the United States. ...

  • Newsfile24 days ago

    CVR Medical Announces Proposed Financing

    Vancouver, British Columbia--(Newsfile Corp. - January 31, 2018) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") announces that it intends to complete a private placement financing for gross proceeds of up to $2,000,000 (the "Financing"), which is expected to consist of units, with each unit comprised of one common share and one-half of one common share purchase warrant at a price of $0.40 per unit, or such other price per unit determined ...

  • Newsfilelast month

    CVR Medical Corp.: Rapid Progress Toward FDA Submission - Clinical Trials Commence At Henry Ford Hospital

    Vancouver, British Columbia--(Newsfile Corp. - January 23, 2018) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") announces the commencement of clinical data acquisition by the Carotid Stenotic Scan (CSS) device at the renowned Henry Ford Hospital. There is currently one wireless CSS device fully deployed within the Henry Ford system, with two additional devices slated for implementation in the subsequent weeks. This clinical trial plays a crucial role in accelerating clinical substantiation for the CSS device and ...

  • Newsfilelast month

    IIROC Trade Resumption - CVR Medical Corp.

    Vancouver, British Columbia--(Newsfile Corp. - January 18, 2018) - Trading resumes in: Company: CVR Medical Corp. TSX-V Symbol: CVM ...

  • Newsfilelast month

    Clarification of News Release on "CVR Medical Enters China, Executes Preliminary LOI to Launch Its CSS Device in World's Largest Market" Dated January 17, 2018

    Vancouver, British Columbia--(Newsfile Corp. - January 18, 2018) - Investment Inventory Regulatory Organization of Canada ("IIROC"), has requested CVR Medical Corp. (TSXV: CVM) ("CVR Medical" or "CVR") to re-state its press release entitled "CVR Medical Enters China, Executes Preliminary LOI To Launch Its CSS Device In World's Largest Market" dated January 17, 2018, (the "January 17, 2018 Release") with increased specificity with regard to the LOI between CVR Medical and Guangzhou LangRun Equity Investment ...

  • Newsfilelast month

    IIROC Trade Halt - CVR Medical Corp.

    Vancouver, British Columbia--(Newsfile Corp. - January 18, 2018) - The following issues have been halted by IIROC: Company:  CVR Medical Corp. TSX-V Symbol: CVM ...

  • Newsfilelast month

    CVR Medical Enters China, Executes Preliminary LOI To Launch Its CSS Device In World's Largest Market

    Potential To Bring Innovation, Sweeping Change To Healthcare in China Vancouver, British Columbia--(Newsfile Corp. - January 17, 2018) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") is pleased to announce the signing of an official Letter of Intent with Guangzhou LangRun Equity Investment Management Co., Ltd. (GLR), a professional equity investment fund management platform company headquartered in Guangzhou, China. GLR plans to create the "LangRun Asset Fund" focused on ...

  • Newsfilelast month

    CVR Medical Eyes Expansion, Global Potential in South Korea

    Vancouver, British Columbia--(Newsfile Corp. - January 11, 2018) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") is pleased to announce the signing of an official Memorandum of Understanding with the Seoul Metropolitan Government (SMG) of the Republic of South Korea. The Understanding states the mutual interest and intended collaboration on new business opportunities as part of CVR's global market expansion and the South Korean government's initiative to revitalize its bio-medical device ...

  • Newsfile2 months ago

    CVR Medical & Henry Ford Hospital - A Giant Leap Forward

    Vancouver, British Columbia--(Newsfile Corp. - January 9, 2018) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") is pleased to announce IRB approval of clinical trials for its "Carotid Stenotic Scan (CSS)" device at Michigan's prestigious Henry Ford Hospital. The trials will be overseen by Judith Lin, MD, MBA, RVT, RPVI, Senior Staff Vascular Surgeon and Medical Director of Henry Ford's Clinical Vascular Laboratory.The Henry Ford Health System, founded in ...

  • Newsfile2 months ago

    CVR Medical, Canon Sign Manufacturing Agreement for Breakthrough Device

    Vancouver, British Columbia--(Newsfile Corp. - January 2, 2018) - CVR Medical Corp. (TSX.V: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") announces the signing of a manufacturing agreement with Canon Virginia, Inc., a manufacturing, engineering and technical operation for Canon and a wholly owned subsidiary of Canon U.S.A. The agreement finalizes Canon Virginia's status as primary manufacturer, assembler, and logistical authority for CVR's "Carotid Stenotic Scan (CSS)" device. CVR's novel device, currently undergoing final phase trials ...

  • Newsfile3 months ago

    CVR Medical Meets Critical Milestone! Deploys Wireless System at Thomas Jefferson University

    Vancouver, British Columbia--(Newsfile Corp. - November 21, 2017) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") announces the full integration of the "Carotid Stenotic Scan (CSS)" wireless device into its late stage, ongoing clinical trials being conducted at Thomas Jefferson University. The wireless system is the key component of the novel device's efficient and user-friendly design. The wireless Intellectual Property in CVR's portfolio fortifies barrier to entry."We have now ...

  • Newsfile3 months ago

    CVR Medical Teams with Rogan Molding Technologies

    Vancouver, British Columbia--(Newsfile Corp. - November 15, 2017) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") announces partnership with Rogan Molding Technologies. The Northbrook, IL company will be the exclusive manufacturer of the patient-interfacing gel pad for CVR's "Carotid Stenotic Scan (CSS)."Founded in 1934, Rogan Molding Technologies is a staple organization in original equipment manufacturing, and a global leader in the injection molding industry. Being ISO 9001 and 13485 certified, ...

  • Newsfile5 months ago

    CVR Medical Bolsters Finance, Quality Systems with Knisley

    Vancouver, British Columbia--(Newsfile Corp. - September 28, 2017) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") announces the addition of Mr. Tim Knisley as Director of Finance and Controlling. Knisley will spearhead the building of CVR's financial systems as they transition from research and development-based to commercial-ready with the launch of the "Carotid Stenotic Scan (CSS)" device.Mr. Tim Knisley has worked in the medical device industry for over twenty ...

  • Newsfile5 months ago

    CVR Medical Expanding Scope, Executive Board with Chinese Leadership Expansion

    Vancouver, British Columbia--(Newsfile Corp. - September 20, 2017) - CVR Medical Corp. (TSXV: CVM) (FSE:B3BN) (OTCQB: CRRVF) ("CVR Medical") enters discussions with Key Opinion Leaders in the Chinese cardiovascular health industry, with whom the organization intends to extend membership on the executive board to. The medical and business influence of these leaders will spur the growth of international opportunities for CVR and its "Carotid Stenotic Scan (CSS)" device.In addition, CVR announces the recent start of ...

  • Newsfile5 months ago

    CVR Medical Names Alan Langston, Tech Industry Standout, VP of Sales and Marketing

    Vancouver, British Columbia--(Newsfile Corp. - September 14, 2017) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") announces the addition of Mr. Alan Langston to the company's executive staff. Langston assumes the position of Vice President of Sales and Marketing, responsible for creating and implementing market entry strategies for the company's "Carotid Stenotic Scan (CSS)" device.Mr. Langston brings with him a decorated history across a broad spectrum of the tech industry ...

  • Newsfile5 months ago

    CVR Medical Announces Institutional Research Report

    Vancouver, British Columbia--(Newsfile Corp. - September 11, 2017) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") is pleased to announce that an institutional research report has been released by RB Milestone Group, LLC ("RBMG"). The report on CVR Medical titled "Revolutionizing the Vascular Diagnostics Market" can be found on the website at www.CVRMed.com or by contacting Trevor Brucato, Managing Director at RBMG.CVR Medical CEO Peter Bakema, speaking on the publishing ...

  • Newsfile6 months ago

    First Trial Data Report: Positive Findings, High Expectations for CVR Medical

    Vancouver, British Columbia--(Newsfile Corp. - September 7, 2017) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") advisory staff member Dr. Phillip J. Bendick, PhD, has released a summarized report on data from the tertiary clinical trials for the "Carotid Stenotic Scan (CSS)" device at Thomas Jefferson University (see press release dated June 29th, 2017). His report views initial evaluations as successful, and confirms the device's value and efficiency.Dr. Bendick's report ...

  • Newsfile6 months ago

    Dr. Phillip Bendick, Preeminent Vascular Sonographer Joins CVR Medical

    Vancouver, British Columbia--(Newsfile Corp. - August 22, 2017) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") is pleased to announce the addition of Dr. Phillip J. Bendick, PhD, to the company's advisory staff. Dr. Bendick, a renowned medical sonographer and researcher, will assist CVR in the organization of expanded clinical trials for the "Carotid Stenotic Scan (CSS)" device. Dr. Bendick will bring a wealth of knowledge and an extensive ...

  • Newsfile7 months ago

    Stroke Prevention Makes Quantum Leap into the Future: CVR Inks Deal with Canon Virginia

    Vancouver, British Columbia--(Newsfile Corp. - August 8, 2017) - CVR Global Inc., on behalf of CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical"), has signed a letter of intent with Canon Virginia, Inc. (CVI), Canon U.S.A., Inc.'s domestic manufacturing subsidiary, for the manufacturer of CVR's Carotid Stenotic Scan (CSS). The CSS is a device being developed for early detection of carotid arterial health, a leading indicator of Stroke.CVR's pairing with ...

  • CVR Medical Announces Independent Report on Clinical Trial Results from Thomas Jefferson University Hospital
    Newsfile8 months ago

    CVR Medical Announces Independent Report on Clinical Trial Results from Thomas Jefferson University Hospital

    Vancouver, British Columbia--(Newsfile Corp. - June 29, 2017) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") is pleased to announce that Thomas Jefferson University Hospital — Jefferson Clinical Research Institute has issued an initial trial report, summarizing the clinical trial progress of the Carotid Stenotic Scan (CSS) under the supervision of Principal Investigator Dr. David Whellan MD, MHS, FACC, FAHA. Dr. Whellan commented, "The ENTICES (Evaluation of a Novel ...

  • Newsfile9 months ago

    CVR Medical Announces Issuance of Shares for Services

    Vancouver, British Columbia--(Newsfile Corp. - June 2, 2017) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") is pleased to announce that CVR Medical has obtained TSX Venture Exchange approval to issue 243,850 common shares of CVR Medical at a deemed price of $0.3375 per share (the "Shares"), as payment to the Lubow Group that was due for their consulting services pursuant to a consulting agreement with an effective date of January ...